Zobrazeno 1 - 10
of 147
pro vyhledávání: '"H van Krieken"'
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
S. van de Weerd, A. Torang, M. Smit, I. van den Berg, J. Roelands, W. Mesker, D. Bedognetti, P. Kuppen, H. Putter, R.A.E.M. Tollenaar, W.R.L. Hendrickx, C. Jimenez, G. Vink, M. Koopman, J. Roodhart, J. Ijzermans, H. van Krieken, J-P. Medema
Publikováno v:
Annals of Oncology. 33:S691-S692
SO-16 The tumour-stroma ratio as an additional parameter to the TNM classification: The UNITED study
Autor:
Hans Gelderblom, Wilma E. Mesker, H. van Krieken, G W van Pelt, Marloes A Smit, R.A.E.M. Tollenaar
Publikováno v:
Annals of Oncology. 31:S222-S223
Autor:
Albert G. Siebers, Kelly Dufraing, Gaston Demonty, Dequeker Emc, Cleo Keppens, KafatosG, Kimberly Lowe, J H Van Krieken
Laboratories require customized feedback on improving biomarker testing practices. A workshop was organized for laboratories that participated in a European external quality assessment scheme to resolve issues related to the estimation of neoplastic
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::46992f47ee035a771c2a47e037aa4e8f
https://lirias.kuleuven.be/handle/123456789/644727
https://lirias.kuleuven.be/handle/123456789/644727
Publikováno v:
Leukemia & Lymphoma, pp. 1-4
Leukemia & Lymphoma, 56, 6, pp. 1891-4
Leukemia & Lymphoma, 1-4
STARTPAGE=1;ENDPAGE=4;ISSN=1042-8194;TITLE=Leukemia & Lymphoma
Leukemia & Lymphoma, 56, 1891-4
Leukemia & Lymphoma, 56, 6, pp. 1891-4
Leukemia & Lymphoma, 1-4
STARTPAGE=1;ENDPAGE=4;ISSN=1042-8194;TITLE=Leukemia & Lymphoma
Leukemia & Lymphoma, 56, 1891-4
Lymphocytic variant hypereosinophilic syndrome (L-HES) is a benign T-cell lymphoproliferative disorder, wherein clonal T-cells often display a CD3 − CD4+ phenotype and produce large amounts of inte...
Autor:
D. van Bladel, M. van den Brand, J. Rijntjes, A. Brinkman, T. Reigl, N. Darzentas, C. Hess, K. Hebeda, P. Groenen, H. van Krieken, B. Scheijen
Publikováno v:
HemaSphere. 3:209
Autor:
Jos Rijntjes, Blanca Scheijen, H. van Krieken, Konnie M. Hebeda, Nikos Darzentas, Corine J. Hess, M. van den Brand, Tomáš Reigl, Patricia J. T. A. Groenen, A. Brinkman, D. van Bladel
Publikováno v:
HemaSphere. 3:209
Autor:
L I, Overbeek, R P, Hermens, J H, van Krieken, E M, Adang, M, Casparie, F M, Nagengast, M J, Ligtenberg, N, Hoogerbrugge, R P, Akkermans
Publikováno v:
Virchows Archiv, 456, 653-9
Virchows Archiv, 456, 6, pp. 653-9
Virchows Archiv
Virchows Archiv, 456, 6, pp. 653-9
Virchows Archiv
Contains fulltext : 88721.pdf (Publisher’s version ) (Open Access) We investigated success factors for the introduction of a guideline on recognition of Lynch syndrome in patients recently diagnosed with colorectal cancer (CRC) below age 50 or a se
Autor:
P van Cleef, Anna Onnis, Cristiana Bellan, Lorenzo Leoncini, Joshua Nyagol, Bessie Byakika, Mario Cocco, Piero Tosi, Stefano Lazzi, G De Falco, Eleonora Leucci, H. van Krieken, A.F. van Rijk
Publikováno v:
Journal of Pathology, 216, 440-50
Journal of Pathology, 216, 4, pp. 440-50
Journal of Pathology, 216, 4, pp. 440-50
Contains fulltext : 69103.pdf (Publisher’s version ) (Closed access) The molecular feature of Burkitt lymphoma (BL) is the translocation that places c-Myc under the control of immunoglobulin gene regulatory elements. However, there is accumulating
Autor:
Joannes H. van Krieken
Publikováno v:
Pathology Patterns Reviews. 122:S122-S127
Lymphoproliferations in patients with immune deficiency form a challenge for the pathologist. The histologic features often are not specific and might even be deceptive. The demonstration of the presence of the Epstein-Barr virus is important, prefer